Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.46 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7600152 | 1.00 | NPSR1 (0.46) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL6044972 | 0.83 | NPSR1 (0.45) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL12317093 | 0.83 | NPSR1 (0.45) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL9889451 | 0.83 | NPSR1 (0.45) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL8160444 | 0.81 | NPSR1 (0.43) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL5144385 | 0.81 | NPSR1 (0.43) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL9281644 | 0.81 | NPSR1 (0.43) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL5963299 | 0.81 | ALDH1A1 (0.50) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL5963296 | 0.81 | ALDH1A1 (0.50) | NPSR1GLO1SOAT1ALDH1A1LMNA | |
| SCHEMBL8583764 | 0.81 | NPSR1 (0.43) | NPSR1GLO1SOAT1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399327-A1 | HIGH ACTIVITY HPK1 KINASE INHIBITOR | ADLAI NORTYE BIOPHARMA CO., LTD. (CN) | 2023-12-14 | — | — | US | disclosed |
| US-20230212183-A9 | INHIBITORS OF KRAS G12C | ARAXES PHARMA LLC (US) | 2023-07-06 | — | — | US | disclosed |
| US-20180207140-A1 | Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation | Sanford Burnham Prebys Medical Discovery Institute | 2018-07-26 | — | — | US | disclosed |
| US-10011600-B2 | Methods and compositions for inhibition of Ras | ARAXES PHARMA LLC (US) | 2018-07-03 | — | — | US | disclosed |
| US-20180140523-A1 | ALKALINE AGENT FOR LIGHTENING HAIR CONTAINING OXIDANTS AND SPECIAL CARBOXYLIC ACID ESTERS | HENKEL AG & CO. KGAA (DE) | 2018-05-24 | — | — | US | disclosed |
| US-20180127373-A1 | PROCESS FOR THE SYNTHESIS OF IVACAFTOR AND RELATED COMPOUNDS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-05-10 | — | — | US | disclosed |
| US-20180118757-A1 | SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C | ARAXES PHARMA LLC | 2018-05-03 | — | — | US | disclosed |
| US-9931334-B2 | Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-04-03 | — | — | US | disclosed |
| US-20180071297-A1 | TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-ALPHA SYNTHESIS AND AS PDE4 INHIBITORS | VTV THERAPEUTICS LLC | 2018-03-15 | — | — | US | disclosed |
| US-9840516-B2 | Substituted quinazolines as inhibitors of KRAS G12C | ARAXES PHARMA LLC (US) | 2017-12-12 | — | — | US | disclosed |
| US-20110053934-A1 | COMPOUNDS AND METHODS OF TREATMENT | GLAXOSMITHKLINE LLC (US) | 2011-03-03 | — | — | US | disclosed |
| US-6441044-B1 | CROP PROTECTION AGENT | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-27 | — | — | US | disclosed |
| EP-0401286-B1 | PROCESS FOR PREPARING N-(HYDROXYALKYL)-2-UNSATURATED AMIDES AND 2-ALKENYL OXAZOLINES | DOW CHEMICAL CO (US) | 1995-09-13 | — | — | EP | disclosed |
| EP-0341475-B1 | STEREO ISOMERS OF N-(R)-1-ARYL-ETHYL)-1-ALKYL-2,2-DICHLOROCYCLOPROPANE CARBOXAMIDE | BAYER AG (DE) | 1993-09-29 | — | — | EP | disclosed |
| EP-0401286-A4 | PROCESS FOR PREPARING N-(HYDROXYALKYL)-2-UNSATURATED AMIDES AND 2-ALKENYL OXAZOLINES | DOW CHEMICAL CO (US) | 1991-07-24 | — | — | EP | disclosed |
| US-5034536-A | Amidation of an ester in the presence of a polymerization inhibitor | THE DOW CHEMICAL COMPANY (US) | 1991-07-23 | — | — | US | disclosed |
| US-4988734-A | Fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 1991-01-29 | — | — | US | disclosed |
| EP-0401286-A1 | PROCESS FOR PREPARING N-(HYDROXYALKYL)-2-UNSATURATED AMIDES AND 2-ALKENYL OXAZOLINES. | DOW CHEMICAL CO (US) | 1990-12-12 | — | — | EP | disclosed |
| EP-0341475-A2 | Stereo isomers of N-(R)-1-aryl-ethyl)-1-alkyl-2,2-dichlorocyclopropane carboxamide | BAYER AG (DE) | 1989-11-15 | — | — | EP | disclosed |
| WO-1989008099-A1 | PROCESS FOR PREPARING N-(HYDROXYALKYL)-2-UNSATURATED AMIDES AND 2-ALKENYL OXAZOLINES | THE DOW CHEMICAL COMPANY (US) | 1989-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180207140-A1 | Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation | NR3C1, NR3C2, GRK3 | NPSR1 679/4885GLO1 3604/4885SOAT1 1129/4885 |
| US-20180127373-A1 | PROCESS FOR THE SYNTHESIS OF IVACAFTOR AND RELATED COMPOUNDS | AVPR1A, ACVR1, AVPR2 | NPSR1 272/4885GLO1 3128/4885SOAT1 1780/4885 |
| US-20230399327-A1 | HIGH ACTIVITY HPK1 KINASE INHIBITOR | MAP3K9, MAP3K1, MAP3K15 | NPSR1 4732/4885GLO1 4041/4885SOAT1 2653/4885 |
| US-20110053934-A1 | COMPOUNDS AND METHODS OF TREATMENT | RET, ABL1, PRKACA | NPSR1 3649/4885GLO1 4469/4885SOAT1 3049/4885 |
| US-20180118757-A1 | SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C | KRAS, NRAS, HRAS | NPSR1 4618/4885GLO1 1508/4885SOAT1 4586/4885 |
| US-20180071297-A1 | TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-ALPHA SYNTHESIS AND AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE4C | NPSR1 3394/4885GLO1 3345/4885SOAT1 2741/4885 |
| US-20230212183-A9 | INHIBITORS OF KRAS G12C | KRAS, NRAS, HRAS | NPSR1 4528/4885GLO1 1529/4885SOAT1 4249/4885 |
| US-10011600-B2 | Methods and compositions for inhibition of Ras | KRAS, NRAS, HRAS | NPSR1 4689/4885GLO1 1761/4885SOAT1 3597/4885 |
| US-20180140523-A1 | ALKALINE AGENT FOR LIGHTENING HAIR CONTAINING OXIDANTS AND SPECIAL CARBOXYLIC ACID ESTERS | KRT18, ALDH7A1, ALDH1A2 | NPSR1 4234/4885GLO1 980/4885SOAT1 2545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.